European Archives - Page 231 of 1002 - European Medical Journal

Precision Medicine-Based Platform to Guide the Treatment of EML4-ALK Lung Cancers and Other Non-Small Cell Lung Cancers

Lung cancer (LC) remains the top cause of cancer-associated mortality worldwide, with a 10-year overall survival rate of only 5%.1…

Isolated Tumour Cells in Early Endometrial Carcinomas

Endometrial cancer is the most common gynaecologic malignancy in high-income countries due to increased life expectancy. Approximately…

Programmed Death-Ligand 1 Expression and its Relation to EML4-ALK Gene Variants in Metastatic Lung Adenocarcinoma: A Single Centre Real-World Experience

Targeted therapy and immunotherapy have revolutionised the treatment of metastatic non-small cell lung cancer, particularly adenocarcinoma…

ESMO 2023 Abstract Highlights

FOR the first time, there is an alternative to chemotherapy for patients with advanced or metastatic urothelial carcinoma. The results of a…

Improving Inclusivity and Diversity in Clinical Trials

Although clinical trials form the backbone of evidence-based medicine, cohorts participating in clinical trials are often poorly…

Dostarlimab and Radiotherapy in A Patient with MSI-H/dMMR Endometrial Cancer

Endometrial carcinoma (EC) is the world’s most common gynaecological malignancy, with a global incidence of 382,069 new cases and 89,929…

Spotlight: November 2023

GOLD looks back at some of the top pharma news stories of the past month including new appointments, regulatory wins and surprising survey results.

Impact of In-House PCR Testing for Candida auris on Hospital-Onset Cases

Testing for Candida auris on patient admission helped to identify more cases, and reduced the number of hospital-onset cases, according to a new study. Read more.

Patients with HIV at Risk for Mental Health Disorders

According to research, people with an HIV diagnosis are more likely to develop a mental health disorder, such as anxiety and depression. Patients who are not receiving treatment for HIV were at an even higher risk.

Results of the ATLANTIS Trial: A Randomised Controlled Trial of Amitriptyline as Second-Line Treatment for IBS in Primary Care

This webinar explores the ATLANTIS trial, a randomised controlled trial investigating amitriptyline as second-line treatment for irritable…